Akèy › Melanom › Kalifòni › San Diego
Etid klinik pou Melanom nan San Diego, CA
18 etid pou Melanom ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
- Research Site, San Diego
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Ap rekriteFaz 3
- UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Pan-tumor MRD Study
Ap rekriteEtid obsèvasyon
- Medical Oncology Associates of San Diego (MOASD), San Diego
- Medical Oncology Associates of San Diego, San Diego
Intratumoral N17350 in Advanced Solid Tumors
Ap rekriteFaz 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Ap rekriteFaz 2
- Sharp Memorial Hospital, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Ap rekriteEtid obsèvasyon
- University of California, San Diego, La Jolla · 11 mi lwen
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Ap rekriteFaz 1/2
- University of California-San Diego, La Jolla · 11 mi lwen
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Ap rekriteFaz 1
- University of California San Diego, Moores Cancer Center, San Diego
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Ap rekriteFaz 1/2
- UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Rady Children's Hospital - San Diego, San Diego
- Naval Medical Center -San Diego, San Diego
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Ap rekriteFaz 2
- UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Ap rekriteFaz 3
- UCSD Moores Cancer Center, La Jolla · 11 mi lwen
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Ap rekriteFaz 2/3
- UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Ap rekriteFaz 1/2
- Research Site, La Jolla · 11 mi lwen
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Ap rekriteEtid obsèvasyon
- UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, La Jolla · 11 mi lwen
A Beta-only IL-2 ImmunoTherapY Study
Ap rekriteFaz 1/2
- Sharp Memorial Hospital, San Diego
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Etid Melanom nan lòt vil
- Houston, TX59 etid
- New York City, NY38 etid
- Los Angeles, CA34 etid
- Nashville, TN33 etid
- Pittsburgh, PA31 etid
- Boston, MA26 etid
- Philadelphia, PA23 etid
- San Francisco, CA22 etid
- Columbus, OH21 etid
- St. Louis, MO21 etid
- Salt Lake City, UT21 etid
- Durham, NC21 etid
Lòt etid nan San Diego
- Kansè Poumon ki pa ti selil48 etid
- Kansè nan tete41 etid
- Kansè (tout kalite)32 etid
- Kansè pwostat31 etid
- Kansè Metastatik30 etid
- Kansè kolorektal25 etid
- Kansè ovè24 etid
- Kansè pankreyas24 etid
- Kansè poumon23 etid
- Obèsite23 etid
- Ensifizyans kadyak23 etid
- Depresyon21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.